METASTATIC ADENOID CYSTIC CARCINOMA
Clinical trials for METASTATIC ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug targets Notch-Activated cancer before surgery
Disease control CompletedThis phase 1 trial tested the drug AL101 in 13 people with a rare salivary gland cancer called adenoid cystic carcinoma that has a specific genetic change (notch activation). Participants received AL101 before their standard surgery to see if it is safe and might help control the…
Matched conditions: METASTATIC ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New scan could help track rare Cancer's response to treatment
Diagnosis CompletedThis pilot study tested whether a special PET/CT scan using a radioactive tracer called Ga-68 PSMA-11 can detect treatment response in patients with metastatic adenoid cystic carcinoma, a rare salivary gland cancer. Six adults with this cancer underwent the scan at two time point…
Matched conditions: METASTATIC ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 26, 2026 15:54 UTC